MedPath

Clinical role of 11C-methionine PET/CT in renal cell carcinoma

Not Applicable
Completed
Conditions
Neoplasms
Registration Number
KCT0006218
Lead Sponsor
Yonsei University Health System, Severance Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

1) Patients with clinically suspected primary kidney cancer (renal cell carcinoma)
2) Patients undergoing diagnostic tests for staging after being confirmed as primary kidney cancer
3) Patients planning nephrectomy due to suspected kidney cancer
4) The age allowed to participate in the study is adults between 20 and 90 years old.

Exclusion Criteria

1) Patients suspected of having metastatic cancer other than primary renal cancer or diagnosed with metastatic cancer
2) Patients diagnosed with benign tumors other than primary kidney cancer
3) Pregnant patients, nursing mothers
4) children

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tumor Stage Prediction
Secondary Outcome Measures
NameTimeMethod
Overall survival and Progression free survival
© Copyright 2025. All Rights Reserved by MedPath